These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 16077078)

  • 1. Re: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Kunkler I
    J Natl Cancer Inst; 2005 Aug; 97(15):1162-3; author reply 1163-4. PubMed ID: 16077078
    [No Abstract]   [Full Text] [Related]  

  • 2. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More evidence that locoregional radiation therapy improves survival: what should we do?
    Whelan T; Levine M
    J Natl Cancer Inst; 2005 Jan; 97(2):82-4. PubMed ID: 15657332
    [No Abstract]   [Full Text] [Related]  

  • 4. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
    Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
    Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center.
    Truong PT; Woodward WA; Thames HD; Ragaz J; Olivotto IA; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):59-65. PubMed ID: 17321065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of two randomized trials evaluating adjuvant anthracycline-based chemotherapy in 1146 patients with early breast cancer.
    Arriagada R; Spielmann M; Koscielny S; Le Chevalier T; Delozier T; Rémé-Saumon M; Ducourtieux M; Tursz T; Hill C
    Acta Oncol; 2005; 44(5):458-66. PubMed ID: 16118079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiation and concomitant chemotherapy after surgery for breast cancer].
    Calais G
    Cancer Radiother; 2004 Feb; 8(1):39-47. PubMed ID: 15093200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of definitive radiation therapy for primary breast cancer on ability to deliver adjuvant chemotherapy.
    Lippman ME; Edwards BK; Findlay P; Danforth DW; MacDonald H; D'Angelo T; Gorrell C
    NCI Monogr; 1986; (1):99-104. PubMed ID: 3534597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial.
    Toledano A; Azria D; Garaud P; Fourquet A; Serin D; Bosset JF; Miny-Buffet J; Favre A; Le Floch O; Calais G
    J Clin Oncol; 2007 Feb; 25(4):405-10. PubMed ID: 17264336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation after mastectomy in high-risk patients: is it necessary?
    Patterson S; Ko A; O'Connell TX
    Am Surg; 2001 Dec; 67(12):1209-12. PubMed ID: 11768832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 disease.
    Aksu G; Kucucuk S; Fayda M; Saynak M; Baskaya S; Saip P; Ozturk N; Aslay I
    Eur J Surg Oncol; 2007 Apr; 33(3):285-93. PubMed ID: 17145158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.
    ; Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
    J Clin Oncol; 2006 May; 24(15):2268-75. PubMed ID: 16618947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wide-field radiation as adjunct to adjuvant chemotherapy in high-risk cases with early breast cancer: do it or not?
    Ragaz J; Spinelli JJ
    Int J Cancer; 2000 Aug; 87(3):423-6. PubMed ID: 10897049
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current status of treatment for early-stage invasive breast cancer].
    Kásler M; Polgár C; Fodor J
    Orv Hetil; 2009 May; 150(22):1013-21. PubMed ID: 19465349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy.
    Oh JL; Dryden MJ; Woodward WA; Yu TK; Tereffe W; Strom EA; Perkins GH; Middleton L; Hunt KK; Giordano SH; Oswald MJ; Domain D; Buchholz TA
    J Clin Oncol; 2006 Nov; 24(31):4971-5. PubMed ID: 17075114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.
    Overgaard M; Nielsen HM; Overgaard J
    Radiother Oncol; 2007 Mar; 82(3):247-53. PubMed ID: 17306393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast.
    Taylor ME; Haffty BG; Rabinovitch R; Arthur DW; Halberg FE; Strom EA; White JR; Cobleigh MA; Edge SB
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):997-1002. PubMed ID: 19251087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of stage I-IIA breast cancer of medial-central localization].
    Datsenko VS
    Khirurgiia (Mosk); 1998; (11):35-7. PubMed ID: 9864983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.